๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis

โœ Scribed by Sasaki, Motoko; Nakanuma, Yasuni; Ho, Samuel B.; Kim, Young S.


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
792 KB
Volume
185
Category
Article
ISSN
0022-3417

No coin nor oath required. For personal study only.

โœฆ Synopsis


The significance of bile ductular proliferation in the progression of various hepatobiliary diseases remains unclear. Increased expression of MUC6 apomucin, a major gastric mucin, has previously been noticed in proliferating bile ductules in chronic viral hepatitis. The purpose of the present study was to characterize MUC6 apomucin and mRNA expression in 35 histologically 'normal livers', 47 livers with chronic viral hepatitis, 28 with primary biliary cirrhosis, and seven with extrahepatic biliary obstruction. MUC6 protein was expressed focally in cytoplasm and/or on the luminal surface of septal and interlobular bile ducts in normal and diseased livers. Bile ductules in normal livers rarely expressed MUC6 protein. The MUC6 expression intensified and spread in proliferating bile ductules and small bile ducts in chronic viral hepatitis and to a lesser degree in other diseases. In the former, the extent and degree of MUC6 expression paralleled the degree of active necroinflammation. MUC6 mRNA expression resembled MUC6 protein expression in proliferating bile ductules and intralobular small biliary cells, suggesting increased transcription and synthesis of MUC6. In conclusion, proliferating bile ductular cells express MUC6 apomucin in diseased liver, especially in chronic viral hepatitis with active necroinflammation. This secreted mucin may act as a cytoprotective agent and represent a phenotype of reactive biliary epithelium in chronic viral hepatitis. 1998


๐Ÿ“œ SIMILAR VOLUMES


Frequent expression of MUC1 apomucin on
โœ M Sasaki; Y Nakanuma ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 323 KB ๐Ÿ‘ 1 views

restricted recognition process. (HEPATOLOGY 1996;23: MUC1 apomucin is a specific target tumor antigen rec-1313-1317.) ognized by cytotoxic T cells in a major histocompatibility complex (MHC) unrestricted fashion in patients with pancreatic and breast cancer. This T-cell-mediated im- Mucin is compos